+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Pseudomonas Aeruginosa Infection Treatment Market - Product Thumbnail Image

Pseudomonas Aeruginosa Infection Treatment Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Markets for Infectious Disease Treatments - Product Thumbnail Image

Global Markets for Infectious Disease Treatments

  • Report
  • December 2021
  • 245 Pages
  • Global
From
From
Antifungal Drugs: Technologies and Global Markets 2021-2026 - Product Thumbnail Image

Antifungal Drugs: Technologies and Global Markets 2021-2026

  • Report
  • November 2021
  • 295 Pages
  • Global
From
From
From
From
From
U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027 - Product Thumbnail Image

U.S. Gene Therapy Market - Industry Outlook & Forecast 2022-2027

  • Report
  • March 2022
  • 208 Pages
  • United States
From
Small Molecule Drug Discovery - Global Strategic Business Report - Product Thumbnail Image

Small Molecule Drug Discovery - Global Strategic Business Report

  • Report
  • November 2024
  • 184 Pages
  • Global
From
Cold Pain Therapy Global Market Report 2024 - Product Thumbnail Image

Cold Pain Therapy Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
From
From
From
From
From
New Drug Delivery Systems Market 2022-2026 - Product Thumbnail Image

New Drug Delivery Systems Market 2022-2026

  • Report
  • February 2022
  • 120 Pages
  • Global
From
Loading Indicator